AstraZeneca pulls critical breast cancer and endometriosis drug Zoladex from shelves
A life-saving breast cancer and endometriosis drug will be pulled from Australian shelves by a major global drug manufacturer later this year, in a move some women have described as “cruel” and “soul-destroying”. Goserelin 3.6mg implant, also known as Zoladex, will be removed from both the Pharmaceutical Benefits Scheme (PBS) and the private market in…